Additionally, with equivocal findings in DR and NAION, discussing personalized ocular risk of starting GLP-1RA in patients is key, and considering increased follow-up frequency after medication initiation may be warranted
Many mild to moderate tears respond well to non-surgical management, including: Activity modification and rest to reduce stress on the joint Physical therapy to restore strength, flexibility, and range of motion Anti-inflammatory medications to relieve pain and reduce swelling Surgery for Hip Labral Tears When non-surgical care isn't sufficient, hip arthroscopy may be recommended
This endeavor not only aligns with the scientific pursuit of knowledge, but also directly addresses the concerns raised by the reviewers, ensuring that the discussion is both comprehensive and relevant to the broader context of cancer treatment
April 11, 2024: Ozempic Lawsuit Joint Defense Statement Filed by Novo Nordisk and Eli Lilly Defendants Novo Nordisk and Eli Lilly have submitted a joint statement of the case in the ongoing Ozempic lawsuit